Literature DB >> 18340332

Update: recommendations from the Advisory Committee on Immunization Practices (ACIP) regarding administration of combination MMRV vaccine.

.   

Abstract

On February 27, 2008, new information was presented to the Advisory Committee on Immunization Practices (ACIP) regarding the risk for febrile seizures among children aged 12-23 months after administration of the combination measles, mumps, rubella, and varicella (MMRV) vaccine (ProQuad, Merck & Co., Inc., Whitehouse Station, New Jersey). This report summarizes current knowledge regarding the risk for febrile seizures after MMRV vaccination and presents updated ACIP recommendations that were issued after presentation of the new information. These updated recommendations remove ACIP's previous preference for administering combination MMRV vaccine over separate injections of equivalent component vaccines (i.e., measles, mumps, and rubella [MMR] vaccine and varicella vaccine).

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18340332

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN： 0149-2195            Impact factor:   17.586


  9 in total

1.  Near real-time surveillance for influenza vaccine safety: proof-of-concept in the Vaccine Safety Datalink Project.

Authors:  Sharon K Greene; Martin Kulldorff; Edwin M Lewis; Rong Li; Ruihua Yin; Eric S Weintraub; Bruce H Fireman; Tracy A Lieu; James D Nordin; Jason M Glanz; Roger Baxter; Steven J Jacobsen; Karen R Broder; Grace M Lee
Journal:  Am J Epidemiol       Date:  2009-12-04       Impact factor: 4.897

Review 2.  Successes and challenges in varicella vaccine.

Authors:  Orestis Papaloukas; Georgia Giannouli; Vassiliki Papaevangelou
Journal:  Ther Adv Vaccines       Date:  2014-03

3.  Using Disease Epidemiology to Optimize Immunization Schedules.

Authors:  Cindy M Weinbaum; Walter A Orenstein
Journal:  JAMA Pediatr       Date:  2017-10-01       Impact factor: 16.193

4.  Statement on Measles-Mumps-Rubella-Varicella Vaccine: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI)†.

Authors:  Ben Tan; Shainoor Ismail
Journal:  Can Commun Dis Rep       Date:  2010-09-21

5.  Perspectives on vaccines against varicella-zoster virus infections.

Authors:  Anne A Gershon; Michael D Gershon
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

6.  Current trends of immunization in Nigeria: prospect and challenges.

Authors:  Endurance A Ophori; Musa Y Tula; Azuka V Azih; Rachel Okojie; Precious E Ikpo
Journal:  Trop Med Health       Date:  2014-04-23

7.  Varicella: epidemiological aspects and vaccination coverage in the Veneto Region.

Authors:  Vincenzo Baldo; Tatjana Baldovin; Francesca Russo; Marta Cecilia Busana; Cinzia Piovesan; Greta Bordignon; Aurore Giliberti; Renzo Trivello
Journal:  BMC Infect Dis       Date:  2009-09-08       Impact factor: 3.090

Review 8.  Varicella vaccination in Europe - taking the practical approach.

Authors:  Paolo Bonanni; Judith Breuer; Anne Gershon; Michael Gershon; Waleria Hryniewicz; Vana Papaevangelou; Bernard Rentier; Hans Rümke; Catherine Sadzot-Delvaux; Jacques Senterre; Catherine Weil-Olivier; Peter Wutzler
Journal:  BMC Med       Date:  2009-05-28       Impact factor: 8.775

9.  Annual report on adverse events related with vaccines use in Calabria (Italy): 2012.

Authors:  Orietta Staltari; Felisa Cilurzo; Benedetto Caroleo; Alexia Greco; Francesco Corasaniti; Maria Antonietta Genovesi; Luca Gallelli
Journal:  J Pharmacol Pharmacother       Date:  2013-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.